BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/20/2014 6:36:00 PM | Browse: 291 | Download: 429
Publication Name World Journal of Gastroenterology
Manuscript ID 9778
Country of Manuscript Source China
Received
2014-02-27 14:17
Peer-Review Started
2014-02-27 21:13
To Make the First Decision
2014-04-15 20:06
Return for Revision
2014-04-27 12:18
Revised
2014-05-12 03:25
Second Decision
2014-06-13 16:01
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-13 16:09
Articles in Press
2014-06-13 16:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-07-03 21:12
Typeset the Manuscript
2014-09-27 14:59
Publish the Manuscript Online
2014-10-20 18:35
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Case Report
Article Title Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Hong-Bo Huan, Wan-Yee Lau, Feng Xia, Kuan-Sheng Ma and Ping Bie
Funding Agency and Grant Number
Correspondence To Feng Xia, MD, PhD, Institute of Hepatobiliary Surgery, Southwest Hospital, Southwest Cancer Center, Third Military Medical University, No. 30 Gaotanyan Street, Shapingba District, Chongqing 400038, China. txzzxf@163.com
Keywords Hepatocellular carcinoma; Partial hepatectomy; Sorafenib; Complete response
Core Tip For patients with multiple recurrent hepatocellular carcinoma (HCC) after partial hepatectomy which cannot be treated by re-hepatectomy or local ablative therapy, the prognosis is extremely poor. Our case showed that the patient with recurrent HCC treated with sorafenib can achieve a complete clinical response as it did in advanced HCC.
Publish Date 2014-10-20 18:35
Citation Huan HB, Lau WY, Xia F, Ma KS, Bie P. Complete response to sorafenib in a patient with recurrent hepatocellular carcinoma. World J Gastroenterol 2014; 20(39): 14505-14509
Url http://www.wjgnet.com/1007-9327/full/v20/i39/14505.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i39.14505
Full Article (PDF) WJG-20-14505.pdf
Full Article (Word) WJG-20-14505.doc
Revised Manuscript 9778-Review.doc
Peer-review Report 9778-Peer review(s).pdf
Answering Reviewers 9778-Answering reviewers.pdf
Scientific Misconduct Check 9778-CrossCheck.jpg
Scientific Editor Work List 9778-Scientific editor work list.pdf
Copyright License Agreement 9778-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 9778-Language certificate.pdf